← Evidence map

ReviewDrugs2010

Antiplatelet drugs--do we need new options? With a reappraisal of direct thromboxane inhibitors.

Sergio CoccheriPubMed ↗Publisher ↗

No numbers read from the abstract.

10 papers cite it

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

this papercites it

Antiplatelet drugs--do we need new options? With a reappraisal of direct thromboxane inhibitors. | OpenQuestion